{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026335","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2024-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.924034+00:00","generated_at":"2026-05-31T23:21:33.105300+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Oncocyte annual meeting elects directors, ratifies auditor; Board confirms Arno independence","bullets":["Shareholders elected four director nominees (Riggs, Arno, Last, Silverman) with ~7.98M votes each; quorum 81.5%.","Ratified Marcum LLP as auditor for FY2024: 10.8M for, 10.9k against, 11k abstain.","Approved non-binding say-on-pay proposal: 8.12M for, 20k against, 11k abstain.","Board determined Andrew Arno independent per Nasdaq rules as of July 1, 2024; Arno chairs Compensation, Last chairs Audit, Silverman chairs Nominating."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026335","json":"https://secwatch.observer/filing/0001493152-24-026335.json","markdown":"https://secwatch.observer/filing/0001493152-24-026335.md","text":"https://secwatch.observer/filing/0001493152-24-026335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224026335/0001493152-24-026335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224026335/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:21:33.105300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}